The two countries would be signing an MoU to foster research cooperation in biotechnology, the visiting premier said, addressing Indian industry captains at a conference organised by business chambers CII, FICCI and Assocham. \n\n
Global pharmaceutical major Teva is planning collaborations with Indian partners for clinical research and biotechnology.
Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
India and the Netherlands on Tuesday signed a memorandum of understanding for cooperation in biotechnology with an aim to find solutions to problems in agricultural and health
India and America sign an agreement to jointly pursue reasearch in vision care.
Asserting that India offers unprecedented opportunities for entrepreneurs in biotechnology industry, Minister of State for Science and Technology Kapil Sibal has invited venture capitalists, experts in the field and non-resident Indians to invest the
In a statement, the PMO said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. It further said Indian Scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.
Scientists associated with Indian SARS-CoV-2 Consortium on Genomics (INSACOG), the government panel that conducts research on different variants of the coronavirus, said they were surprised at noted virologist Shahid Jameel's decision to quit the group and wondered whether he was disillusioned with the government's handling of the pandemic.
The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.
Approximately 72% people wear inappropriate sized footwear which is associated with all kind of foot problems.
In a weekly series, CollegePond.com provides answers all your queries related to pursuing an education abroad.
Head of Epidemiology and Communicable diseases at the ICMR Dr Raman R Gangakhedkar said the apex health research body will begin a study on the effectiveness of the vaccine against coronavirus infection next week.
As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
Knowledge of technical skills, creativity, social and emotional intelligence is what recruiters are looking for.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.
Green revolution and technology use should not be region-specific.
The Institute of Bioinformatics and Applied Biotechnology, Bangalore, announces admissions for its third batch, 2004-2005.
The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.
The 'Age of Rage' survey by Tata Salt Lite revealed some startling facts about the causes of stress and anxiety among urban Indians.
Biotechnology industry worldwide is poised to achieve profitability by 2010, offering an opportunity to Indian companies to strike alliances with global firms.
The serious glitches in the Biotechnology Regulatory Authority of India Bill.
Learn how the founder of India's first and largest biotechnology company dealt with failure and achieved success.
